Lanlan Wei
Harbin Medical University
41 Papers
106 Citations
Lanlan Wei is an academic researcher from Harbin Medical University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 15, co-authored 30 publications. Previous affiliations of Lanlan Wei include Southern University of Science and Technology.
Chat about Author
Papers
The SARS-CoV-2 inactivated vaccine enhances the broad neutralization against variants in individuals recovered from COVID-19 up to one year
Xinrong Zhou,Lin Cheng,Haiyan Wang,Xuejiao Liao,Miao Wang,Lanlan Wei,Shuo Song,Bing Zhou,Zhenghua Ma,Huimin Guo,Xiangyang Ge,Bin Ju,Zheng Zhang +12 more
TL;DR: The SARS-CoV-2 inactivated vaccine enhances the broad neutralization against variants in individuals recovered from COVID-19 up to one year.
7
Characterization of two new monoclonal antibodies against human papillomavirus type 16 L1 protein.
TL;DR: Two new monoclonal antibodies (mAbs) against HPV L1 protein are characterized to help develop genetic-engineered neutralizing antibodies against HPV16 for diagnostic and therapeutic purposes.
DisV-HPV16, versatile and powerful software to detect HPV in RNA sequencing data.
Bingqing Yan,Xinyi Liu,Siwei Zhang,Siyang Yu,Fangjia Tong,Huanhuan Xie,Lianhao Song,Yan Zhang,Lanlan Wei +8 more
TL;DR: DisV-HPV16 is a new, dependable software to detect virus and viral oncogenes expression through analysis of RNA sequencing data and can yield deeper, more comprehensive insights into virus infection status and viral and host cell gene expression.
HRRD: a manually-curated database about the regulatory relationship between HPV and host RNA
Bingqing Yan,Siwei Zhang,Siyang Yu,Sajjad Hussain,Tianyang Liu,Bozhi Wang,Xiaoyu Dong,Fen Ma,Lanlan Wei +8 more
TL;DR: A database named HRRD is presented, which contains the regulatory relationship between HPV and RNA (mRNA, miRNA and lncRNA) and it is hoped it will further provide a comprehensive understanding of HPV in carcinogenesis and prognosis.
Abstract 6213: Disruption of XPF function by HPV promotes alternative end joining and sensitivity to cisplatin in HNSCC
Qi Liu,Nan Zuo,Lin Ma,Lanlan Wei +3 more
TL;DR: Liu et al. as mentioned in this paper investigated the effect of XPF inhibition on the effects of cisplatin on head and neck squamous cell carcinoma (HNSCC) cells.